endeavor clinical trials logo
request appointment with endeavor clinical trials
210.949.0807
Same Day Appointments Available With Endeavor Clinical Trials Of San Antonio, TX

News

June 3, 2019

Endeavor Clinical Trials participates in Positive Topline Data from Second Pivotal Phase 3 Study of Intravenous Tramadol in the Management of Postoperative Pain

Endeavor Clinical Trials was one of the sites that participated in the second pivotal Phase 3 trial of IV tramadol achieved the primary endpoint of a statistically significant improvement in Sum of Pain Intensity Difference over 24 hours (SPID24) compared to placebo in patients with postoperative pain following abdominoplasty surgery. In addition, the trial met all of its key secondary endpoints. The study also includes a standard-of-care IV opioid as an active comparator: IV morphine 4 mg. In this study, IV tramadol also demonstrated similar efficacy and safety to that of IV morphine.

CLICK HERE to read about the positive topline results from the phase 3 clinical trial


October 3, 2018

Endeavor interview on KEDA Radio

Dr. Sherwyn Schwartz, Lisa Rodriguez, and Henry Rodriguez pose for a picture after their time on-the-air at KEDA radio.

Dr. Sherwyn Schwartz, Lisa Rodriguez, and Henry Rodriguez discuss new initiative to reach San Antonio Hispanic community with Type II Diabetes.


September 18, 2018

TECH SA: New device measures temperatures for diabetics at risk of foot ulcers

Device is connected to app for convenience, makers say

Endeavor Clinical Trials the sole site selected to study the device prior to going to market.

CLICK HERE to read about the device and how it helps diabetics at risk of foot ulcers.


March 20, 2018

Endeavor Clinical Trials participates in bringing new non-opioid pain control medicine to the market

Endeavor Clinical Trials was one of the sites that participated in studies investigating a non-opioid postoperative pain medicine. The sponsor, Heron Therapeutics, has announced positive topline results from its completed Phase 3 studies of the investigational agent HTX-011 in subjects undergoing bunionectomy (Study 301/EPOCH1) and hernia repair (Study 302/EPOCH2). HTX-011 achieved all primary and key secondary endpoints in both Phase 3 trials, demonstrating statistically significant reductions in both pain intensity and the use of opioid rescue medications through 72 hours following surgery.

CLICK HERE to read about the positive topline results from the phase 3 clinical trials.


October 18, 2017

Potential Solution to Opioid Addiction Epidemic Being Tested in San Antonio

READ a local news story featuring our very own Dr. Pollak on the opioid crisis and how new studies are working to combat the issue.

current trials at endeavor podiatry clinical trials upcoming trials at endeavor podiatry clinical trials what to expect at endeavor podiatry clinical trials frequently asked questions endeavor podiatry clinical trials

read what our patients have to say ...

endeavor clinical trials logo
Request Appointment
Endeavor Clinical Trials Of
San Antonio, TX

Physicians Plaza II
8042 Wurzbach #420
San Antonio, Texas 78229
Office: (210) 949-0807
Fax: (210) 692-7647
scrs logo



endeavor clinical trials on facebook
Endeavor Clinical Trials of San Antonio, Texas (TX) has over 20 years of experience conducting research and clinical trials specializing in surgical, orthopedic and specialty medicine. Our licensed and board certified San Antonio podiatrists have helped over 150,000 patients find relief for their foot or ankle pain, and are committed to the discovery of new medicine to improve the lives of people everywhere. Our current clinical trials include, Athletes Foot Clinical Trial, Bunion Clinical Trial, Toenail Fungus Clinical Trial and more. If you live in or around San Antonio, TX, New Braunfels, TX, Seguin, TX, Kerville, TX, Victoria, TX or Pleasanton, TX, call Endeavor Clinical Trials today.
© 2019 Endeavor Clinical Trials | San Antonio Clinical Trials
Designed by JimmyMarketing.com
Powered By: Boss Creative | thisisboss.com